Villanueva, Jerum Jr. A.
HRN: 23-70-76 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/17/2023
CEFTAZIDIME 1GM (VIAL)
09/17/2023
09/23/2023
IV
530mg
Q8H
Immunocompromised State
Waiting Final Action
Indication: ProphylaxisEmpiric Type of Infection: Bloodstream Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes